Huiqiang Huang, Male, born in 1962. Associate Professor of Medical Oncology.

Mailing Address: 
Department of Medical Oncology,
Cancer Center, Zhongshan University
651 Dongfeng Road, East 
GuangZhou ,510060
P. R. China
E-mail address : HUANGHQ@public.guangzhou.gd.cn
  
Educational and Professional Background
1979 - 1984: Faculty of Medicine ZhongShan Medical College
1984 - 1987: Residence Department of Medical Oncology ,Cancer Center, Sun Yat-Sen University of Medical Sciences (SUMS).
1987 - 1990 :Studying for the Master Degree of Cancer Chemotherapy, SUMS
1990 - 1995: Visiting Doctor Department of Medical Oncology, Cancer Center, SUMS
1995 - June,1999, Studying for the Ph.D. , associate professor, Department of Medical Oncology, Cancer Center, SUMS
July,1999- Present :associate professor, Ph. D. and MD , Department of Medical Oncology ,Cancer Center, Zhongshan University.
 
Clinical Studies: ( co-research)
1. National multicenter clinical trial : Application of high dose chemotherapy supported by autologous peripheral blood progenitors transplantation in the treatment of malignant tumors.
2. Phase II clinical trial :hrG-CSF application in leucopenic patients induced by chemotherapy
3. Phase I and II clinical trial: Dimethyl phenylatriazene ( DM-PTA ) for the treatment of malignant tumors
4. Multicenter clinical trial (SDA) : Phase I and Phase II Clinical Study of Dimethyl phenylatriazene (DM-PTA) for Treatment of Malignancies
5. Multicenter clinical trial ( SDA ) : Phase II clinical trial of PF in the treatment of malignancie
6. Phase II clinical study of NAVANTRONE in the treatment of advanced nasopharyngeal carcinoma
 
Grant :
1. Scientific and Technological Committee of Guangdong Province and Health Bureau of Guangdong Province: Clinical and Experimental study of multicyclic dose-intensive chemotherapy in solid tumors supported by hemotopoietic progenitors in whole blood
2. Bureau of Public Health,Guangdong Province : Clinical study of multicyclic dose-intensive chemotherapy in solid tumors supported by hematopoietic progenitors in whole blood
   
Publications
1.The preliminary result of high dose chemotherapy (HDC) supported by prepheral blood progenitor cells transplantation (PBPCT) in the treatment of non-Hodgkins lymphoma (NHL)
     Huang Hui-qiang, Guan Zhongzhen, He Youjian, et al Chinese Journal of Cancer 1997,16 (3) :217-218
2.The preliminary result of high dose chemotherapy(HDC)supported by autollogous hemotopoietic progenitor cells transplantation in the treatment of solid tumours 
Huang Hui-qiang, Sun Xiaofei, Liu Donggen, et al Chinese Journal of Cancer ( Suppl ) 1997,16 :217-218
3. A phase II clinical trial in the treatment of advanced Nasopharyngeal Carcinoma ( NPC ) with Novantrone 
Huang Hui-qiang Guan Zhongzhen He Youjian Chinese Journal of Cancer 1996 ,15 (6) 443 -445
4. The preliminary result of DDP,5-Fu and High-Dose Leucovorin ( HDCF) for advanced or reccurent nasopharyngeal carcinoma (NPC ) 
He Youjian, Huang Hui-qiang, Chinese Journal of Cancer 1994 ,13 (3) :239-239
5. Chemotherapy of Nasopharyngeal Carcinoma-- A preliminary evaluation of treatment response and possible potentiation effect of ADPRT inhibitor Nicotinamide.  
Huang Hui-qiang , Guan Zhongzhen, Chinese Journal of Cancer 1992 ,2 (3) :229
6. Nasopharygeal Carcinoma Guan Zhongzhen Huang Hui-qiang Chemoprevention and Drug Therapy of Cancer (1991) Chief-Editor :
HangRui Publishing House of Beijing University of Medical Sciences and Concort Medical University of China. 527 -535
7. Priliminary result of DDP,5-Fu and High dose Leucovorin ( HDCF ) plus Interferon for the treatment of advance or recurrent Nasopharygeal Carcinoma 
Huang Hui-qiang, Li Yu-hong, He You-jian: et al Chinese Journal of Cancer 1998,17(6):450-2
8. Clinical trial of 5 Fu/CF and carboplatin combination chemotherapy in patients with advanced nasopharygeal carcinoma (NPC) 
Li Yu-hong, He You-jian, Huang Hui-qiang: et al Chinese Journal of Cancer 1999,18(3 ):295 – 6.
9. Peripheral blood progenitors mobilized by chemotherapy and G-CSF (Filgrastim) in maglinant solid tumor. 
Huang Hui-qiang, Jiang Wen-qi, Sun Xiao-fei, Kong Qing-yu , Li Yong-qiang , Cai Ti-yu, Luo Hui-ling:
Chinese Journal of Clinical Oncology ,2001 ,9 to be published.
10.The impact of hematopoietic inhibitors MIP-1αon cytokine-induced polifera -tion of peripheral blood progenitor cells. 
Huang Hui-qiang , Jiang Wen- qi Li , Yong-qiang Cai , Ti-yu Luo , Hui-ling Sun xin 
Chinese Journal of experimental Hematology ,2000 (to be published)
11. Phase I and Phase II Clinical Study of Dimethyl phenylatriazene (DM-PTA) for Treatment of Malignancies Huang Hui-qiang , Guan Zhong-zhen, He You-jiang , Liu Mao-zen , Zhou Zhong-mei , Li Yu-hong , Zhang Li , Liu Dong-geng , Chinses Journal of Cancer ,2001,20(12):56-59.
12. Advanced and Recurrent malignant Lymphoma were Treated by BEAC Regimen Supported with autologous hematopoietic Stem cells Transplantation (AHSCT)
Huang Hui-qiang , Jiang Wen-qi , Guan Zhong-zhen, He You-jiang, Sun Xiaofei , Liu Donggen , Lin Tong-yu, Xu Rui-hua, Zhou Zhong-mei, Chinese Journal of Cancer, 2001, 20(4) 394- 398.
13 . Case Report:Pneumocystic Carini infection in patients with Non-Hodgkin’s lymphoma following systemic chemotherapy Huang Yun-hong Huang Hui-qiang Chinese Journal of Cancer 2000,19 (6) :56
14 . Priliminary Results of Ifofamide and Doxorubicin Regimen in the treatment of recurrent and metastaticn asopharygeal carcinoma Huang Hui-qiang, ZHOU Zhong-mei , JIANG Wen-qi , HE You-jian, LI Yi-hong, GUAN Zhong-zhen Chinese Journal of Cancer ,2001.9 to be published.
15 .Preliminary results of advanced and recurrent malignant lymphoma treated by BEAC regimen supported with autologous hematopoietic stem cells transplantation Huang Hui-qiang Guan Zhong-zhen HE You-jiang et al Chinese Journal of Cancer Research 2001,12 to be published
16 . Advances in autologous hematopoietic stem cell transplantation HUANG
Hui-qiang GUAN Zhong-zhen Journal of Practical Oncology 2001,16(5):7-9
Professional Society Memberships:
Association for Anti-Cancer, Guangdong, 
Society of Chemotherapy association for Hematology, Guangdong, 
Society of Hematologic Maglinancy.